Atai Life Sciences N.V.
ATAI
$4.76
-$0.07-1.45%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 95.94M | 98.20M | 62.33M | 85.92M | 88.35M |
Total Receivables | 1.31M | 1.49M | 1.35M | 6.95M | 12.08M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 33.00K | 392.00K | 772.00K | 1.07M | 59.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 5.40M | 15.89M | 15.68M | 20.13M | 17.43M |
Total Current Assets | 102.68M | 115.98M | 80.13M | 114.07M | 117.91M |
|
|||||
Total Current Assets | 102.68M | 115.98M | 80.13M | 114.07M | 117.91M |
Net Property, Plant & Equipment | 5.70M | 5.59M | 3.87M | 1.90M | 1.92M |
Long-term Investments | 331.00K | 331.00K | 331.00K | -- | -- |
Goodwill | 331.00K | 331.00K | 331.00K | -- | -- |
Total Other Intangibles | 3.12M | 3.16M | 3.25M | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 6.61M | 5.60M | 850.00K | 2.43M | 2.43M |
Total Assets | 189.20M | 195.78M | 159.39M | 197.52M | 215.78M |
|
|||||
Total Accounts Payable | 4.04M | 2.71M | 2.62M | 4.88M | 3.81M |
Total Accrued Expenses | 14.08M | 7.51M | 9.66M | 11.66M | 12.35M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 6.60M | 14.78M | 9.84M | 2.66M | 239.00K |
Total Finance Division Other Current Liabilities | 830.00K | 3.50M | 2.84M | 439.00K | 1.25M |
Total Other Current Liabilities | 830.00K | 3.50M | 2.84M | 439.00K | 1.25M |
Total Current Liabilities | 25.55M | 28.50M | 24.95M | 19.64M | 17.64M |
|
|||||
Total Current Liabilities | 25.55M | 28.50M | 24.95M | 19.64M | 17.64M |
Long-Term Debt | 2.50M | 11.60M | 16.33M | 22.74M | 20.86M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 2.62M | 2.59M | 732.00K | 808.00K | 838.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 14.61M | 821.00K | 817.00K | 8.02M | 7.91M |
Total Liabilities | 45.28M | 43.51M | 42.83M | 51.20M | 47.25M |
|
|||||
Common Stock & APIC | 919.03M | 897.84M | 834.97M | 827.13M | 822.02M |
Retained Earnings | -754.37M | -726.64M | -700.21M | -661.25M | -634.96M |
Treasury Stock & Other | -20.93M | -19.15M | -18.47M | -20.16M | -19.17M |
Total Common Equity | 143.74M | 152.05M | 116.30M | 145.72M | 167.89M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 143.74M | 152.05M | 116.30M | 145.72M | 167.89M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 187.00K | 221.00K | 257.00K | 596.00K | 643.00K |
Total Equity | 143.93M | 152.27M | 116.55M | 146.32M | 168.53M |
|